RecruitingPhase 2NCT06198842

Low Dose Treosulfan Based Conditioning Regimen and PTCy in HSCT for Nijmegen Breakage Syndrome

Studying Nijmegen breakage syndrome

Last synced from ClinicalTrials.gov May 14, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Intervention: Treosulfan(drug)
Enrollment: 10 enrolled
Eligibility: 21 years · All sexes
Timeline: 2023 – 2029

Study locations (1)

HSCT department, Moscow, Russia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06198842 on ClinicalTrials.gov

← Back to all trials